161 related articles for article (PubMed ID: 10064389)
1. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
[TBL] [Abstract][Full Text] [Related]
2. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
3. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.
Tornos C; Soslow R; Chen S; Akram M; Hummer AJ; Abu-Rustum N; Norton L; Tan LK
Am J Surg Pathol; 2005 Nov; 29(11):1482-9. PubMed ID: 16224215
[TBL] [Abstract][Full Text] [Related]
4. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
6. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid.
Ostrowski ML; Merino MJ
Am J Surg Pathol; 1996 Aug; 20(8):964-74. PubMed ID: 8712296
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up.
Achille G; Garrisi VM; Russo S; Guastamacchia E; Giagulli VA; Schirosi L; Daniele A; Tufaro A; Cafagna V; Centrone M; Simone G; Abbate I; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):213-218. PubMed ID: 28558632
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-associated antigens in routinely embedded carcinomas. Possibilities and limitations studied in 116 cases.
Logmans SC; Jöbsis AC
Cancer; 1984 Jul; 54(2):274-9. PubMed ID: 6202390
[TBL] [Abstract][Full Text] [Related]
9. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a histological and immunohistochemical study of three cases.
Chan JK; Tsui MS; Tse CH
Histopathology; 1987 Feb; 11(2):191-201. PubMed ID: 2437003
[TBL] [Abstract][Full Text] [Related]
10. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
Kavishwar VS; Phatak AM; Rege JD
Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628
[TBL] [Abstract][Full Text] [Related]
12. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous occurrence of medullary and papillary carcinoma of the thyroid gland identified by fine needle aspiration. A case report.
Merchant FH; Hirschowitz SL; Cohan P; Van Herle AJ; Natarajan S
Acta Cytol; 2002; 46(4):762-6. PubMed ID: 12146049
[TBL] [Abstract][Full Text] [Related]
14. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors.
Judkins AR; Roberts SA; Livolsi VA
Hum Pathol; 1999 Nov; 30(11):1373-6. PubMed ID: 10571520
[TBL] [Abstract][Full Text] [Related]
15. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin immunoreactivity in lymph node histiocytes: a potential diagnostic pitfall.
Venkatraman L; Maxwell P; McCluggage WG
J Clin Pathol; 2001 Apr; 54(4):314-6. PubMed ID: 11304850
[TBL] [Abstract][Full Text] [Related]
17. The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast.
Lee AH; Paish EC; Marchio C; Sapino A; Schmitt FC; Ellis IO; Reis-Filho JS
Histopathology; 2007 Dec; 51(6):824-8. PubMed ID: 18042071
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovaries.
Householder J; Han A; Edelson MI; Eager JM; Rosenblum NG
Arch Pathol Lab Med; 2002 Sep; 126(9):1101-3. PubMed ID: 12204061
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of thyroid adenomas with Hurthle cells.
Kanthan R; Radhi JM
Pathology; 1998 Feb; 30(1):4-6. PubMed ID: 9534199
[TBL] [Abstract][Full Text] [Related]
20. Thyroglobulin immunostaining in follicular thyroid carcinoma: relationship to the degree of differentiation and cell type.
Harach HR; Franssila KO
Histopathology; 1988 Jul; 13(1):43-54. PubMed ID: 3061922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
